$中慧生物-B(02_老虎社区_美港股上老虎

$中慧生物-B(02627)$ 支撑公司高估值的逻辑之一是核心产品四价流感疫苗“慧尔康欣”商业化进展顺利，2025年预期收入有可能会高于市场平均值

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":536524958885184,"tweetId":"536524958885184","gmtCreate":1772008502874,"gmtModify":1772008504873,"author":{"id":4218427800237090,"idStr":"4218427800237090","authorId":4218427800237090,"authorIdStr":"4218427800237090","name":"莎士比亚的微笑","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 支撑公司高估值的逻辑之一是核心产品四价流感疫苗“慧尔康欣”商业化进展顺利，2025年预期收入有可能会高于市场平均值</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 支撑公司高估值的逻辑之一是核心产品四价流感疫苗“慧尔康欣”商业化进展顺利，2025年预期收入有可能会高于市场平均值</p></body></html>","text":"$中慧生物-B(02627)$ 支撑公司高估值的逻辑之一是核心产品四价流感疫苗“慧尔康欣”商业化进展顺利，2025年预期收入有可能会高于市场平均值","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/536524958885184","repostId":0,"isVote":1,"tweetType":1,"viewCount":108,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02627"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":126,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}